Atlas Trials

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL

Clinical trial NCT00209209 · UNKNOWN

Trial details

NCT number
NCT00209209
Sponsor
European Mantle Cell Lymphoma Network
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma, Mantle-Cell
Start date
2004-01-14
Primary completion
2018-12-01
Enrollment
570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.